These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 8736622)
1. Docetaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer. Fulton B; Spencer CM Drugs; 1996 Jun; 51(6):1075-92. PubMed ID: 8736622 [TBL] [Abstract][Full Text] [Related]
2. Docetaxel: an update of its use in advanced breast cancer. Figgitt DP; Wiseman LR Drugs; 2000 Mar; 59(3):621-51. PubMed ID: 10776837 [TBL] [Abstract][Full Text] [Related]
3. Risks and benefits of taxanes in breast and ovarian cancer. Michaud LB; Valero V; Hortobagyi G Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347 [TBL] [Abstract][Full Text] [Related]
4. Docetaxel: a taxoid for the treatment of metastatic breast cancer. Tankanow RM Am J Health Syst Pharm; 1998 Sep; 55(17):1777-91. PubMed ID: 9775340 [TBL] [Abstract][Full Text] [Related]
5. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials. Sparano JA Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388 [TBL] [Abstract][Full Text] [Related]
7. Reflections on the development of resistance during therapy for advanced breast cancer. Implications of high levels of activity of docetaxel in anthracycline-resistant breast cancer patients. Ravdin PM Eur J Cancer; 1997 Aug; 33 Suppl 7():S7-10. PubMed ID: 9486096 [TBL] [Abstract][Full Text] [Related]
8. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions. Goble S; Bear HD Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604 [TBL] [Abstract][Full Text] [Related]
9. Docetaxel (Taxotere): an effective agent in the management of second-line breast cancer. van Oosterom AT Semin Oncol; 1995 Dec; 22(6 Suppl 13):22-8. PubMed ID: 8604449 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel (Taxotere) in combination: a step forward. Burris HA; Fields S; Peacock N Semin Oncol; 1995 Dec; 22(6 Suppl 13):35-40. PubMed ID: 8604452 [TBL] [Abstract][Full Text] [Related]
11. Docetaxel and paclitaxel in breast cancer therapy: present status and future prospects. D'Andrea GM; Seidman AD Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-27-S13-44. PubMed ID: 9335514 [TBL] [Abstract][Full Text] [Related]
12. Docetaxel: a review of its use in non-small cell lung cancer. Comer AM; Goa KL Drugs Aging; 2000 Jul; 17(1):53-80. PubMed ID: 10933515 [TBL] [Abstract][Full Text] [Related]
13. The international experience with docetaxel in the treatment of breast cancer. Ravdin PM Oncology (Williston Park); 1997 Mar; 11(3 Suppl 2):38-42. PubMed ID: 9110341 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and docetaxel in breast and ovarian cancer. Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422 [TBL] [Abstract][Full Text] [Related]
15. Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacy. Valero V Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-11-S13-18. PubMed ID: 9335512 [TBL] [Abstract][Full Text] [Related]
16. A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer. Crown J Semin Oncol; 1999 Feb; 26(1 Suppl 3):5-9. PubMed ID: 10203264 [TBL] [Abstract][Full Text] [Related]
17. The role of taxanes in the treatment of breast cancer. Capri G; Tarenzi E; Fulfaro F; Gianni L Semin Oncol; 1996 Feb; 23(1 Suppl 2):68-75. PubMed ID: 8614849 [TBL] [Abstract][Full Text] [Related]
18. Future perspectives of docetaxel (Taxotere) in front-line therapy. Piccart MJ; Di Leo A Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-27-S10-33. PubMed ID: 9275004 [TBL] [Abstract][Full Text] [Related]
19. Docetaxel in combination chemotherapy for metastatic breast cancer. Khayat D; Antoine E Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513 [TBL] [Abstract][Full Text] [Related]
20. Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: results of a compassionate use program in The Netherlands. Kruijtzer CMF ; Verweij J; Schellens JH; Beijnen JH; Pronk L; Bo M; Lustig V; van Tinteren H; Mackay M; Ten Bokkel Huinink WW Anticancer Drugs; 2000 Apr; 11(4):249-55. PubMed ID: 10898539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]